mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.4 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |